In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Thermo Fisher Scientific nets $1.5bn in FOPO

10 Jun 2021

Executive Summary

Thermo Fisher Scientific Inc. netted $1.5bn in a follow-on public offering through the sale of 8.8mm common shares at $171. The company will use the offering proceeds to pay for a portion of its acquisition of Patheon NV.

Deal Industry
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By